Showing results (31-40 of 433) with videos related to

Sort By:
Pageof 44
Scientific Reports|April 28, 2021
Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitorsDespina Michailidou, Ali Raza Khaki, Maria Pia Morelli, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular SubtypesMichael S Lee, David G Menter, Scott Kopetz
Clinical Colorectal Cancer|April 22, 2022
The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal CancerAlisha Bent, Shreya Raghavan, Arvind Dasari, et al.
Future Oncology (London, England)|February 24, 2018
Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancerAmir Mehrvarz Sarshekeh, Michael J Overman, Scott Kopetz
Digestive Diseases and Sciences|February 15, 2015
Blood-based tests for colorectal cancer screening: do they threaten the survival of the FIT test?Robert S Bresalier, Scott Kopetz, Dean E Brenner
Journal of Gastrointestinal Oncology|March 11, 2017
Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the pieJonathan M Loree, Scott Kopetz, Kanwal P S Raghav
Oncology (Williston Park, N.Y.)|June 21, 2019
Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal CancerHey Min Lee, Van Morris, Stefania Napolitano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2023
PRESSING Need of Precision Care in HER2-Positive Colorectal Cancer: The ELEPHANT in the RoomKanwal P S Raghav, Jonathan M Loree, Scott Kopetz
Investigational New Drugs|July 9, 2002
Endothelin-1 as a target for therapeutic intervention in prostate cancerE Scott Kopetz, Joel B Nelson, Michael A Carducci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2019
Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge TherapiesChristine M Parseghian, Stefania Napolitano, Jonathan M Loree, et al.
Pageof 44